<p>Cryo-Cell International, Inc.是一家在 NYSE American LLC 以 CCEL 為交易代碼的私人臍帶血銀行，成功獲得了細胞治療認證基金會（FACT）對臍帶血採集、儲存和管理（相關和無關）捐贈的認證續期。該公司於 2014 年首次獲得認證，現在又獲得了三年的認證延續。續期認證將有效至 Ap。</p>

CCEL

<p>Cryo-Cell International, Inc.是一家在 NYSE American LLC 上市的私人臍帶血銀行，股票代碼為 CCEL，成功獲得了細胞治療認證基金會（FACT）對臍帶血採集、儲存和用於管理（相關和無關）捐贈的認證續期。該公司於 2014 年首次獲得認證，現在又獲得了三年的認證延續。續期認證將有效至四月</p>

<p>Cryo-Cell International, Inc., a private cord blood bank traded on NYSE American LLC under the symbol CCEL, has successfully obtained renewed Foundation for the Accreditation of Cellular Therapy (FACT) Accreditation for Cord Blood Collection, Banking, and Release for Administration (Related and Unrelated) Donations. Initially accredited in 2014, the company has secured another three-year accreditation extension. The renewed accreditation will remain effective until Ap.</p>
<div class="lb-trans"><p>Cryo-Cell International, Inc.是一家在 NYSE American LLC 以 CCEL 為交易代碼的私人臍帶血銀行，成功獲得了細胞治療認證基金會（FACT）對臍帶血採集、儲存和管理（相關和無關）捐贈的認證續期。該公司於 2014 年首次獲得認證，現在又獲得了三年的認證延續。續期認證將有效至 Ap。</p>
</div>

Cryo-Cell International Receives FACT Re-accreditation, Setting the Longest Independently Validated Quality Track Record Among U.S. Private Cord Blood Banks

Cryo-Cell International 獲得 FACT 重新認證，創下美國私人臍帶血庫中最長的獨立驗證質量記錄